Your browser doesn't support javascript.
loading
Nanobodies: new avenue to treat kidney disease.
Wanner, Nicola; Eden, Thomas; Liaukouskaya, Nastassia; Koch-Nolte, Friedrich.
Afiliação
  • Wanner N; III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. n.wanner@uke.de.
  • Eden T; Institute of Immunology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Liaukouskaya N; III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Koch-Nolte F; Institute of Immunology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Cell Tissue Res ; 385(2): 445-456, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34131806
ABSTRACT
Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / Nefropatias Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / Nefropatias Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article